1
|
Jia X, Luo W, Li J, Xing J, Sun H, Wu S, Su X. A deep learning framework for predicting disease-gene associations with functional modules and graph augmentation. BMC Bioinformatics 2024; 25:214. [PMID: 38877401 DOI: 10.1186/s12859-024-05841-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2024] [Accepted: 06/12/2024] [Indexed: 06/16/2024] Open
Abstract
BACKGROUND The exploration of gene-disease associations is crucial for understanding the mechanisms underlying disease onset and progression, with significant implications for prevention and treatment strategies. Advances in high-throughput biotechnology have generated a wealth of data linking diseases to specific genes. While graph representation learning has recently introduced groundbreaking approaches for predicting novel associations, existing studies always overlooked the cumulative impact of functional modules such as protein complexes and the incompletion of some important data such as protein interactions, which limits the detection performance. RESULTS Addressing these limitations, here we introduce a deep learning framework called ModulePred for predicting disease-gene associations. ModulePred performs graph augmentation on the protein interaction network using L3 link prediction algorithms. It builds a heterogeneous module network by integrating disease-gene associations, protein complexes and augmented protein interactions, and develops a novel graph embedding for the heterogeneous module network. Subsequently, a graph neural network is constructed to learn node representations by collectively aggregating information from topological structure, and gene prioritization is carried out by the disease and gene embeddings obtained from the graph neural network. Experimental results underscore the superiority of ModulePred, showcasing the effectiveness of incorporating functional modules and graph augmentation in predicting disease-gene associations. This research introduces innovative ideas and directions, enhancing the understanding and prediction of gene-disease relationships.
Collapse
Affiliation(s)
- Xianghu Jia
- College of Computer Science and Technology, Qingdao University, Qingdao, 266071, Shandong, China
| | - Weiwen Luo
- College of Computer Science and Technology, Qingdao University, Qingdao, 266071, Shandong, China
| | - Jiaqi Li
- College of Computer Science and Technology, Qingdao University, Qingdao, 266071, Shandong, China
| | - Jieqi Xing
- College of Computer Science and Technology, Qingdao University, Qingdao, 266071, Shandong, China
| | - Hongjie Sun
- College of Computer Science and Technology, Qingdao University, Qingdao, 266071, Shandong, China
| | - Shunyao Wu
- College of Computer Science and Technology, Qingdao University, Qingdao, 266071, Shandong, China.
| | - Xiaoquan Su
- College of Computer Science and Technology, Qingdao University, Qingdao, 266071, Shandong, China.
| |
Collapse
|
2
|
Ansari M, White AD. Learning peptide properties with positive examples only. DIGITAL DISCOVERY 2024; 3:977-986. [PMID: 38756224 PMCID: PMC11094695 DOI: 10.1039/d3dd00218g] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/05/2023] [Accepted: 03/30/2024] [Indexed: 05/18/2024]
Abstract
Deep learning can create accurate predictive models by exploiting existing large-scale experimental data, and guide the design of molecules. However, a major barrier is the requirement of both positive and negative examples in the classical supervised learning frameworks. Notably, most peptide databases come with missing information and low number of observations on negative examples, as such sequences are hard to obtain using high-throughput screening methods. To address this challenge, we solely exploit the limited known positive examples in a semi-supervised setting, and discover peptide sequences that are likely to map to certain antimicrobial properties via positive-unlabeled learning (PU). In particular, we use the two learning strategies of adapting base classifier and reliable negative identification to build deep learning models for inferring solubility, hemolysis, binding against SHP-2, and non-fouling activity of peptides, given their sequence. We evaluate the predictive performance of our PU learning method and show that by only using the positive data, it can achieve competitive performance when compared with the classical positive-negative (PN) classification approach, where there is access to both positive and negative examples.
Collapse
Affiliation(s)
- Mehrad Ansari
- Department of Chemical Engineering, University of Rochester Rochester NY 14627 USA
| | - Andrew D White
- Department of Chemical Engineering, University of Rochester Rochester NY 14627 USA
| |
Collapse
|
3
|
Ansari M, White AD. Learning Peptide Properties with Positive Examples Only. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2023:2023.06.01.543289. [PMID: 37333233 PMCID: PMC10274696 DOI: 10.1101/2023.06.01.543289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/20/2023]
Abstract
Deep learning can create accurate predictive models by exploiting existing large-scale experimental data, and guide the design of molecules. However, a major barrier is the requirement of both positive and negative examples in the classical supervised learning frameworks. Notably, most peptide databases come with missing information and low number of observations on negative examples, as such sequences are hard to obtain using high-throughput screening methods. To address this challenge, we solely exploit the limited known positive examples in a semi-supervised setting, and discover peptide sequences that are likely to map to certain antimicrobial properties via positive-unlabeled learning (PU). In particular, we use the two learning strategies of adapting base classifier and reliable negative identification to build deep learning models for inferring solubility, hemolysis, binding against SHP-2, and non-fouling activity of peptides, given their sequence. We evaluate the predictive performance of our PU learning method and show that by only using the positive data, it can achieve competitive performance when compared with the classical positive-negative (PN) classification approach, where there is access to both positive and negative examples.
Collapse
Affiliation(s)
- Mehrad Ansari
- Department of Chemical Engineering, University of Rochester, Rochester, NY, 14627, USA
| | - Andrew D. White
- Department of Chemical Engineering, University of Rochester, Rochester, NY, 14627, USA
| |
Collapse
|
4
|
Alrefai N, Ibrahim O. Optimized feature selection method using particle swarm intelligence with ensemble learning for cancer classification based on microarray datasets. Neural Comput Appl 2022. [DOI: 10.1007/s00521-022-07147-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
5
|
Machine learning prediction and tau-based screening identifies potential Alzheimer's disease genes relevant to immunity. Commun Biol 2022; 5:125. [PMID: 35149761 PMCID: PMC8837797 DOI: 10.1038/s42003-022-03068-7] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2020] [Accepted: 01/21/2022] [Indexed: 12/19/2022] Open
Abstract
With increased research funding for Alzheimer's disease (AD) and related disorders across the globe, large amounts of data are being generated. Several studies employed machine learning methods to understand the ever-growing omics data to enhance early diagnosis, map complex disease networks, or uncover potential drug targets. We describe results based on a Target Central Resource Database protein knowledge graph and evidence paths transformed into vectors by metapath matching. We extracted features between specific genes and diseases, then trained and optimized our model using XGBoost, termed MPxgb(AD). To determine our MPxgb(AD) prediction performance, we examined the top twenty predicted genes through an experimental screening pipeline. Our analysis identified potential AD risk genes: FRRS1, CTRAM, SCGB3A1, FAM92B/CIBAR2, and TMEFF2. FRRS1 and FAM92B are considered dark genes, while CTRAM, SCGB3A1, and TMEFF2 are connected to TREM2-TYROBP, IL-1β-TNFα, and MTOR-APP AD-risk nodes, suggesting relevance to the pathogenesis of AD.
Collapse
|
6
|
Saikia SJ, Nirmala SR. Identification of disease genes and assessment of eye-related diseases caused by disease genes using JMFC and GDLNN. Comput Methods Biomech Biomed Engin 2021; 25:359-370. [PMID: 34384296 DOI: 10.1080/10255842.2021.1955358] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
Early detection of disease genes helps humans to recover from certain gene-related diseases, like genetic eye diseases. This work identifies the possibility of eye diseasesfor the disease genes utilizing a Gaussian-activation function (G)-centric deeplearning neural network (GDLNN) model. In this work, human genes are selected by computing structural similarity and genes are clustered as disease genesand normal genes by using the JMFC clustering algorithm. Levy flight and Crossover and Mutation (LCM) centric Chicken Swarm Optimization (LCM-CSO) is employed for feature selection and GDLNN classifies the eye-related diseases for the input genes using the selected features.
Collapse
Affiliation(s)
- Samar Jyoti Saikia
- Department of Electronics and Communication Engineering, Gauhati University, Guwahati, Assam, India.,Department of Electronics and Communication Engineering, Assam Don Bosco University, Guwahati, Assam, India
| | - S R Nirmala
- Department of Electronics and Communication Engineering, Gauhati University, Guwahati, Assam, India.,School of Electronics and Communication Engineering, KLE Technological University, Hubli, Karnataka, India
| |
Collapse
|
7
|
Ata SK, Wu M, Fang Y, Ou-Yang L, Kwoh CK, Li XL. Recent advances in network-based methods for disease gene prediction. Brief Bioinform 2020; 22:6023077. [PMID: 33276376 DOI: 10.1093/bib/bbaa303] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2020] [Revised: 09/29/2020] [Accepted: 10/10/2020] [Indexed: 01/28/2023] Open
Abstract
Disease-gene association through genome-wide association study (GWAS) is an arduous task for researchers. Investigating single nucleotide polymorphisms that correlate with specific diseases needs statistical analysis of associations. Considering the huge number of possible mutations, in addition to its high cost, another important drawback of GWAS analysis is the large number of false positives. Thus, researchers search for more evidence to cross-check their results through different sources. To provide the researchers with alternative and complementary low-cost disease-gene association evidence, computational approaches come into play. Since molecular networks are able to capture complex interplay among molecules in diseases, they become one of the most extensively used data for disease-gene association prediction. In this survey, we aim to provide a comprehensive and up-to-date review of network-based methods for disease gene prediction. We also conduct an empirical analysis on 14 state-of-the-art methods. To summarize, we first elucidate the task definition for disease gene prediction. Secondly, we categorize existing network-based efforts into network diffusion methods, traditional machine learning methods with handcrafted graph features and graph representation learning methods. Thirdly, an empirical analysis is conducted to evaluate the performance of the selected methods across seven diseases. We also provide distinguishing findings about the discussed methods based on our empirical analysis. Finally, we highlight potential research directions for future studies on disease gene prediction.
Collapse
Affiliation(s)
- Sezin Kircali Ata
- School of Computer Science and Engineering Nanyang Technological University (NTU)
| | - Min Wu
- Institute for Infocomm Research (I2R), A*STAR, Singapore
| | - Yuan Fang
- School of Information Systems, Singapore Management University, Singapore
| | - Le Ou-Yang
- College of Electronics and Information Engineering, Shenzhen University, Shenzhen China
| | | | - Xiao-Li Li
- Department head and principal scientist at I2R, A*STAR, Singapore
| |
Collapse
|
8
|
Le DH. Machine learning-based approaches for disease gene prediction. Brief Funct Genomics 2020; 19:350-363. [PMID: 32567652 DOI: 10.1093/bfgp/elaa013] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Revised: 04/30/2020] [Accepted: 05/09/2020] [Indexed: 12/20/2022] Open
Abstract
Disease gene prediction is an essential issue in biomedical research. In the early days, annotation-based approaches were proposed for this problem. With the development of high-throughput technologies, interaction data between genes/proteins have grown quickly and covered almost genome and proteome; thus, network-based methods for the problem become prominent. In parallel, machine learning techniques, which formulate the problem as a classification, have also been proposed. Here, we firstly show a roadmap of the machine learning-based methods for the disease gene prediction. In the beginning, the problem was usually approached using a binary classification, where positive and negative training sample sets are comprised of disease genes and non-disease genes, respectively. The disease genes are ones known to be associated with diseases; meanwhile, non-disease genes were randomly selected from those not yet known to be associated with diseases. However, the later may contain unknown disease genes. To overcome this uncertainty of defining the non-disease genes, more realistic approaches have been proposed for the problem, such as unary and semi-supervised classification. Recently, more advanced methods, including ensemble learning, matrix factorization and deep learning, have been proposed for the problem. Secondly, 12 representative machine learning-based methods for the disease gene prediction were examined and compared in terms of prediction performance and running time. Finally, their advantages, disadvantages, interpretability and trust were also analyzed and discussed.
Collapse
Affiliation(s)
- Duc-Hau Le
- Department of Computational Biomedicine, Vingroup Big Data Institute, Hanoi, Vietnam
| |
Collapse
|
9
|
A novel one-class classification approach to accurately predict disease-gene association in acute myeloid leukemia cancer. PLoS One 2019; 14:e0226115. [PMID: 31825992 PMCID: PMC6905554 DOI: 10.1371/journal.pone.0226115] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2019] [Accepted: 11/19/2019] [Indexed: 01/02/2023] Open
Abstract
Disease causing gene identification is considered as an important step towards drug design and drug discovery. In disease gene identification and classification, the main aim is to identify disease genes while identifying non-disease genes are of less or no significant. Hence, this task can be defined as a one-class classification problem. Existing machine learning methods typically take into consideration known disease genes as positive training set and unknown genes as negative samples to build a binary-class classification model. Here we propose a new One-class Classification Support Vector Machines (OCSVM) method to precisely classify candidate disease genes. Our aim is to build a model that concentrate its focus on detecting known disease-causing gene to increase sensitivity and precision. We investigate the impact of our proposed model using a benchmark consisting of the gene expression dataset for Acute Myeloid Leukemia (AML) cancer. Compared with the traditional methods, our experimental result shows the superiority of our proposed method in terms of precision, recall, and F-measure to detect disease causing genes for AML. OCSVM codes and our extracted AML benchmark are publicly available at: https://github.com/imandehzangi/OCSVM.
Collapse
|
10
|
Awaysheh A, Wilcke J, Elvinger F, Rees L, Fan W, Zimmerman KL. Review of Medical Decision Support and Machine-Learning Methods. Vet Pathol 2019; 56:512-525. [DOI: 10.1177/0300985819829524] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
Machine-learning methods can assist with the medical decision-making processes at the both the clinical and diagnostic levels. In this article, we first review historical milestones and specific applications of computer-based medical decision support tools in both veterinary and human medicine. Next, we take a mechanistic look at 3 archetypal learning algorithms—naive Bayes, decision trees, and neural network—commonly used to power these medical decision support tools. Last, we focus our discussion on the data sets used to train these algorithms and examine methods for validation, data representation, transformation, and feature selection. From this review, the reader should gain some appreciation for how these decision support tools have and can be used in medicine along with insight on their inner workings.
Collapse
Affiliation(s)
- Abdullah Awaysheh
- Department of Biomedical Sciences and Pathobiology, VA-MD College of Veterinary Medicine, Blacksburg, VA, USA
| | - Jeffrey Wilcke
- Department of Biomedical Sciences and Pathobiology, VA-MD College of Veterinary Medicine, Blacksburg, VA, USA
| | - François Elvinger
- Virginia Tech, Blacksburg, VA, USA
- Animal Health Diagnostic Center, Cornell University, Ithaca, NY, USA
| | - Loren Rees
- Department of Business Information Technology, Pamplin College of Business, Blacksburg, VA, USA
| | - Weiguo Fan
- Department of Business Information Technology, Pamplin College of Business, Blacksburg, VA, USA
| | - Kurt L. Zimmerman
- Department of Biomedical Sciences and Pathobiology, VA-MD College of Veterinary Medicine, Blacksburg, VA, USA
| |
Collapse
|
11
|
Li F, Zhang Y, Purcell AW, Webb GI, Chou KC, Lithgow T, Li C, Song J. Positive-unlabelled learning of glycosylation sites in the human proteome. BMC Bioinformatics 2019; 20:112. [PMID: 30841845 PMCID: PMC6404354 DOI: 10.1186/s12859-019-2700-1] [Citation(s) in RCA: 52] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2018] [Accepted: 02/22/2019] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND As an important type of post-translational modification (PTM), protein glycosylation plays a crucial role in protein stability and protein function. The abundance and ubiquity of protein glycosylation across three domains of life involving Eukarya, Bacteria and Archaea demonstrate its roles in regulating a variety of signalling and metabolic pathways. Mutations on and in the proximity of glycosylation sites are highly associated with human diseases. Accordingly, accurate prediction of glycosylation can complement laboratory-based methods and greatly benefit experimental efforts for characterization and understanding of functional roles of glycosylation. For this purpose, a number of supervised-learning approaches have been proposed to identify glycosylation sites, demonstrating a promising predictive performance. To train a conventional supervised-learning model, both reliable positive and negative samples are required. However, in practice, a large portion of negative samples (i.e. non-glycosylation sites) are mislabelled due to the limitation of current experimental technologies. Moreover, supervised algorithms often fail to take advantage of large volumes of unlabelled data, which can aid in model learning in conjunction with positive samples (i.e. experimentally verified glycosylation sites). RESULTS In this study, we propose a positive unlabelled (PU) learning-based method, PA2DE (V2.0), based on the AlphaMax algorithm for protein glycosylation site prediction. The predictive performance of this proposed method was evaluated by a range of glycosylation data collected over a ten-year period based on an interval of three years. Experiments using both benchmarking and independent tests show that our method outperformed the representative supervised-learning algorithms (including support vector machines and random forests) and one-class learners, as well as currently available prediction methods in terms of F1 score, accuracy and AUC measures. In addition, we developed an online web server as an implementation of the optimized model (available at http://glycomine.erc.monash.edu/Lab/GlycoMine_PU/ ) to facilitate community-wide efforts for accurate prediction of protein glycosylation sites. CONCLUSION The proposed PU learning approach achieved a competitive predictive performance compared with currently available methods. This PU learning schema may also be effectively employed and applied to address the prediction problems of other important types of protein PTM site and functional sites.
Collapse
Affiliation(s)
- Fuyi Li
- Infection and Immunity Program, Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC 3800 Australia
- Monash Centre for Data Science, Faculty of Information Technology, Monash University, Melbourne, VIC 3800 Australia
| | - Yang Zhang
- College of Information Engineering, Northwest A and F University, Yangling, 712100 Shaanxi China
| | - Anthony W. Purcell
- Infection and Immunity Program, Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC 3800 Australia
| | - Geoffrey I. Webb
- Monash Centre for Data Science, Faculty of Information Technology, Monash University, Melbourne, VIC 3800 Australia
| | - Kuo-Chen Chou
- Gordon Life Science Institute, Boston, MA 02478 USA
- Center for Informational Biology, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054 China
| | - Trevor Lithgow
- Infection and Immunity Program, Biomedicine Discovery Institute and Department of Microbiology, Monash University, Melbourne, VIC 3800 Australia
| | - Chen Li
- Infection and Immunity Program, Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC 3800 Australia
- Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, 8093 Zürich, Switzerland
| | - Jiangning Song
- Infection and Immunity Program, Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC 3800 Australia
- Monash Centre for Data Science, Faculty of Information Technology, Monash University, Melbourne, VIC 3800 Australia
| |
Collapse
|
12
|
Korani W, Clevenger JP, Chu Y, Ozias-Akins P. Machine Learning as an Effective Method for Identifying True Single Nucleotide Polymorphisms in Polyploid Plants. THE PLANT GENOME 2019; 12:180023. [PMID: 30951095 DOI: 10.3835/plantgenome2018.05.0023] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
Single nucleotide polymorphisms (SNPs) have many advantages as molecular markers since they are ubiquitous and codominant. However, the discovery of true SNPs in polyploid species is difficult. Peanut ( L.) is an allopolyploid, which has a very low rate of true SNP calling. A large set of true and false SNPs identified from the Axiom_ 58k array was leveraged to train machine-learning models to enable identification of true SNPs directly from sequence data to reduce ascertainment bias. These models achieved accuracy rates above 80% using real peanut RNA sequencing (RNA-seq) and whole-genome shotgun (WGS) resequencing data, which is higher than previously reported for polyploids and at least a twofold improvement for peanut. A 48K SNP array, Axiom_2, was designed using this approach resulting in 75% accuracy of calling SNPs from different tetraploid peanut genotypes. Using the method to simulate SNP variation in several polyploids, models achieved >98% accuracy in selecting true SNPs. Additionally, models built with simulated genotypes were able to select true SNPs at >80% accuracy using real peanut data. This work accomplished the objective to create an effective approach for calling highly reliable SNPs from polyploids using machine learning. A novel tool was developed for predicting true SNPs from sequence data, designated as SNP machine learning (SNP-ML), using the described models. The SNP-ML additionally provides functionality to train new models not included in this study for customized use, designated SNP machine learner (SNP-MLer). The SNP-ML is publicly available.
Collapse
|
13
|
Vasighizaker A, Jalili S. C-PUGP: A cluster-based positive unlabeled learning method for disease gene prediction and prioritization. Comput Biol Chem 2018; 76:23-31. [PMID: 29890338 DOI: 10.1016/j.compbiolchem.2018.05.022] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2017] [Revised: 04/14/2018] [Accepted: 05/27/2018] [Indexed: 11/25/2022]
Abstract
Disease gene detection is an important stage in the understanding disease processes and treatment. Some candidate disease genes are identified using many machine learning methods Although there are some differences in these methods including feature vector of genes, the method used to selecting reliable negative data (non-disease genes), and the classification method, the lack of negative data is the most significant challenge of them. Recently, candidate disease genes are identified by semi-supervised learning methods based on positive and unlabeled data. These methods are reasonably accurate and achieved more desirable results versus preceding methods. In this article, we propose a novel Positive Unlabeled (PU) learning technique based upon clustering and One-Class classification algorithm. In this regard, unlike existing methods, we make a more Reliable Negative (RN) set in three steps: (1) Clustering positive data, (2) Learning One-Class classifier models using the clusters, and (3) Selecting intersection set of negative data as the Reliable Negative set. Next, we attempt to identify and rank the candidate disease genes using a binary classifier based on support vector machine (SVM) algorithm. Experimental results indicate that the proposed method yields to the best results, that is 92.8, 93.6, and 93.1 in terms of precision, recall, and F-measure respectively. Compared to the existing methods, the increase of performances of our proposed method is 11.7 percent better than the best method in terms of F-measure. Also, results show about 6% increase in the prioritization results.
Collapse
Affiliation(s)
- Akram Vasighizaker
- Computer Engineering Department, Tarbiat Modares University, Tehran, Iran
| | - Saeed Jalili
- Computer Engineering Department, Tarbiat Modares University, Tehran, Iran.
| |
Collapse
|
14
|
|
15
|
Nikdelfaz O, Jalili S. Disease genes prediction by HMM based PU-learning using gene expression profiles. J Biomed Inform 2018; 81:102-111. [PMID: 29571901 DOI: 10.1016/j.jbi.2018.03.006] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2017] [Revised: 11/22/2017] [Accepted: 03/12/2018] [Indexed: 12/24/2022]
Abstract
Predicting disease candidate genes from human genome is a crucial part of nowadays biomedical research. According to observations, diseases with the same phenotype have the similar biological characteristics and genes associated with these same diseases tend to share common functional properties. Therefore, by applying machine learning methods, new disease genes are predicted based on previous ones. In recent studies, some semi-supervised learning methods, called Positive-Unlabeled Learning (PU-Learning) are used for predicting disease candidate genes. In this study, a novel method is introduced to predict disease candidate genes through gene expression profiles by learning hidden Markov models. In order to evaluate the proposed method, it is applied on a mixed part of 398 disease genes from three disease types and 12001 unlabeled genes. Compared to the other methods in literature, the experimental results indicate a significant improvement in favor of the proposed method.
Collapse
Affiliation(s)
- Ozra Nikdelfaz
- Tarbiat Modares University, Computer Engineering Department, Islamic Republic of Iran.
| | - Saeed Jalili
- Tarbiat Modares University, Computer Engineering Department, Islamic Republic of Iran.
| |
Collapse
|